Sign Up
Stories
Polyclonal Antibody Market and CDMO Collaboration
Share
Amgen's Obesity Prospects in Focus
Bayer and Johnson & Johnson's Growth Str...
Bioinformatics Market Insights
AI-Driven Protein Design Revolutionizes ...
Adcetris Boosts Lymphoma Patients' Survi...
Albumin Excipient Market Growth
Overview
API
Global polyclonal antibody market projected to reach USD 2.1 billion by 2030, driven by demand in research, diagnostics, and therapeutics. EUROAPI collaborates with SpiroChem to enhance CDMO capabilities for a consolidated CRO-CDMO solution.
Ask a question
How could the collaboration between EUROAPI and SpiroChem influence the future of drug development?
How might the increasing demand for polyclonal antibodies impact the healthcare industry?
What are the potential implications of a consolidated CRO-CDMO solution for drug development?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage